Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 127,280 | 566 | 376 | 1,792 | 21,482 |
| Gross Profit | 127,280 | 566 | 376 | 1,792 | 21,482 |
| Operating Expenses | 38,920 | 34,243 | 27,064 | 28,319 | 24,929 |
| Operating Income | 88,360 | -33,677 | -26,688 | -26,527 | -3,447 |
| Interest Expense | 1,678 | 1,687 | 1,655 | 1,702 | 892 |
| Other Income | 68 | 82 | 269 | 153 | 1,336 |
| Pre-tax Income | 86,750 | -35,282 | -28,074 | -28,076 | -3,003 |
| Net Income Continuous | 86,750 | -35,282 | -28,074 | -28,076 | -3,003 |
| Net Income | $86,750 | $-35,282 | $-28,074 | $-28,076 | $-3,003 |
| EPS Basic Total Ops | 0.83 | -0.34 | -0.27 | -0.27 | 0.01 |
| EPS Basic Continuous Ops | 0.84 | -0.34 | -0.27 | -0.27 | 0.01 |
| EPS Diluted Total Ops | 0.83 | -0.34 | -0.27 | -0.27 | 0.01 |
| EPS Diluted Continuous Ops | 0.84 | -0.34 | -0.27 | -0.27 | 0.01 |
| EBITDA(a) | $88,566 | $-33,478 | $-26,263 | $-26,110 | $-3,180 |